Bill Details
View committees (1)
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill would require the Department of Health and Human Services to create guidelines aimed at helping Medicare patients take their medicines more regularly. The goal is to reach 90% adherence for drugs covered under Medicare Part B and Part D. In plain terms, it is meant to help people stay on their prescribed treatment plans so medicines work better and health problems are less likely to get worse.
- The health secretary would have to set up these drug adherence guidelines.
- The guidelines would need to use artificial intelligence and machine learning tools where possible.
- The bill says the government should also encourage the use of generic drugs and biosimilar drugs as much as practical.
Official Summaries
This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish drug adherence guidelines for covered drugs under Medicare so as to achieve an adherence rate of 90%. The CMS must incorporate artificial intelligence and machine-learning technologies and promote generics and biosimilars when developing the guidance.
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1142 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1142
To amend the Public Health Service Act to direct the Secretary of
Health and Human Services to establish drug adherence guidelines, and
for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 7, 2025
Mr. Schweikert introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to direct the Secretary of
Health and Human Services to establish drug adherence guidelines, and
for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. ESTABLISHMENT OF DRUG ADHERENCE GUIDELINES.
Title XVII of the Public Health Service Act (42 U.S.C. 300u et
seq.) is amended by inserting after section 1711 (42 U.S.C. 300u-16)
the following:
``SEC. 1712. ESTABLISHMENT OF DRUG ADHERENCE GUIDELINES.
``(a) In General.--The Secretary shall establish drug adherence
guidelines with the goal of achieving 90 percent adherence for all
Medicare part B and D drugs.
``(b) Contents.--In establishing the guidelines under subsection
(a), the Secretary shall--
``(1) incorporate artificial intelligence and machine
learning technologies; and
``(2) to the maximum extent practicable, promote the use of
generic and biosimilar drugs.
``(c) Definitions.--In this section:
``(1) Medicare part b drug.--The term `Medicare part B
drug' means a drug or biological product for which payment may
be made under part B of title XVIII of the Social Security Act
(42 U.S.C. 1395j et seq.).
``(2) Medicare part d drug.--The term `Medicare part D
drug' means a covered part D drug (as defined in section 1860D-
2(e) of the Social Security Act (42 U.S.C. 1395w-102(e))).''.
<all>